19.05.2008

 The Latin American operation is expected to grow rapidly under the guidance of Mr. Podestá and will be primarily focused on supporting our Global Clinical Development brand. Mr. Podestá joins Chiltern with over 9 years experience in clinical research, where he has held executive positions in the CRO sector. Mr. Podestá will be responsible for the strategic development of Chiltern in the Latin America region.

“I am very pleased to join Chiltern at this exciting juncture for the company,” commented Oscar Podestá, General Manager, Latin America. “Argentina and Brazil have long been considered the premier countries for clinical research in Latin America and the strong collaboration between sponsors, CROs, and academic organizations has created a large pool of highly qualified Investigators. Furthermore, regulatory authorities in Argentina (ANMAT) and Brazil (ANVISA) have taken an active role during the last 10 years in establishing a strong legal framework for the ethical conduct of clinical trials in the region, insuring that the highest possible clinical data is attained in accordance with both Good Clinical and Manufacturing practices.”

“We are delighted that Oscar has joined Chiltern,” said John Vann, Executive Vice President, Americas. “His strong background and experience in the region, in particular Argentina and Brazil, will be an asset for Chiltern as our strategic expansion in the region is expected to continue. Additionally, in recent months, there has been an increasing amount of interest from our sponsors to conduct trials in this part of the world, thus the time was right for Chiltern to establish operations in the region. Chiltern is now in a position to support all of its sponsors’ needs throughout Latin America.”

Back to list